Trial
NCT02465957
QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
ImmunityBio, Inc.
Collaborators
—
Condition
Stage IIIB Merkel Cell Carcinoma
Intervention
aNK (NK-92)
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-02